Mumbai (Maharashtra) [India], May 30: Nikkhil K Masurkar, CEO of Mumbai-based ENTOD Pharmaceuticals, has been appointed as the Vice Chairperson of the R&D and Innovation Committee of the Indian Drug Manufacturers Association (IDMA) for the term 2025-2026.
Mumbai-based ENTOD Pharmaceuticals met with the Drug Controller General of India (DCGI) earlier this week to address concerns surrounding PresVu eye drops, which were approved for treating presbyopia in adults on August 6. However, the drug controller suspended its permission on September 10
The drug regulator suspended permission, citing the company's failure to respond to the queries on the product for which the DCGI says "no approval was granted."
The Drugs Controller General of India (DCGI) on Wednesday suspended the product PresVu produced by Entod Pharmaceuticals after the company failed to respond to the queries on the product for which the DGCI says no approval was granted.
The ENTOD Pharmaceuticals declared that they have not made any of the unethical or false presentation of facts to the media or public on PresVu Eye Drops.
The ENTOD Pharmaceuticals claiming PresVU eye drops approved by DCGI offering spectacular treatment for Presbyopia, making with spectacles is unethical and false presentation, said a top official source to ANI.